BACKGROUND AND AIM
Fabry disease (FD) is frequently complicated by renal impairment and cardiovascular events; however, evidence on sodium-glucose cotransporter-2 inhibitors (SGLT2i) in this population is scarce. Accordingly, we assessed the association between SGLT2i exposure and cardiovascular outcomes in adults with...
Leandra Serio, M. Rossi, A. Askarinejad et al.· Diabetes, obesity and metabo...· 0 citations
Three distinct phenotypic clusters were identified, each with heterogeneous clinical characteristics and outcomes, underscoring the need for more individualised, phenotype-informed management strategies in this complex patient population.
A. Askarinejad, T. Bucci, Enrico Tartaglia et al.· European journal of internal...· 0 citations
The GLORIA-AF Bleeding Score showed modestly higher discrimination than HAS-BLED for 1-year major bleeding prediction while retaining clinical interpretability and usability and external validation in independent European and Asia-Pacific registries further supports its transportability beyond the derivation population...
Yi-Fan Xie, Wenhui Li, Yanda Meng et al.· European Journal of Preventi...· 0 citations
External validation of the GLORIA-AF Stroke Weighted Risk Score supports its transportability and potential adjunctive role in guideline-directed thromboembolic risk assessment and generally greater net benefit than CHA2DS2-VA.
